In last trading session, I-Mab ADR (NASDAQ:IMAB) saw 1.83 million shares changing hands with its beta currently measuring 1.32. Company’s recent per share price level of $2.02 trading at -$0.76 or -27.34% at ring of the bell on the day assigns it a market valuation of $159.46M. That closing price of IMAB’s stock is at a discount of -52.48% from its 52-week high price of $3.08 and is indicating a premium of 70.3% from its 52-week low price of $0.60.

For I-Mab ADR (IMAB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

I-Mab ADR (NASDAQ:IMAB) trade information

Upright in the red during last session for losing -27.34%, in the last five days IMAB remained trading in the red while hitting it’s week-highest on Thursday, 06/26/25 when the stock touched $2.02 price level, adding 31.53% to its value on the day. I-Mab ADR’s shares saw a change of 17.44% in year-to-date performance and have moved -13.30% in past 5-day. I-Mab ADR (NASDAQ:IMAB) showed a performance of 94.23% in past 30-days.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 28.36% during past 5 years.

I-Mab ADR (NASDAQ:IMAB)’s Major holders

HHLR ADVISORS, LTD. is the top institutional holder at IMAB for having 6.91 million shares of worth $11.54 million. And as of 2024-06-30, it was holding 7.7935 of the company’s outstanding shares.

The second largest institutional holder is CALIGAN PARTNERS LP, which was holding about 3.37 million shares on 2024-06-30. The number of shares represents firm’s hold over 3.8067 of outstanding shares, having a total worth of $5.64 million.